“The Idf Consensus Worldwide Definition of the Metabolic Syndrome,” 2006. http://www.idf.org/webdata/docs/MetSyndrome_FINAL.pdf.
 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” The Journal of the American Medical Association, Vol. 285, No. 19, 2001, pp. 2486-2497. doi:10.1001/jama.285.19.2486
 J. Tuomilehto, J. Lindstr?m and J. G. Eriksson, “Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance,” The New England Journal of Medicine, Vol. 344, No. 18, 2001, pp. 1343-1350.
 J. Lindstrom, A. Louheranta, M. Mannelin, M. Rastas, V. Salminen and J. Eriksoon, “The Finnish Diabetes Prevention Study (DPS): Lifestyle Intervention and 3-Year Results on Diet and Physical Activity,” Diabetes Care, Vol. 26, No. 12, 2003, pp. 3230-3236.
 D. Al-Qahtani, M. Imtiaz, O. Saad and N. Hussein, “A Comparison of the Prevalence of Metabolic Syndrome in Saudi Adult Females Using Two Definitions,” Metabolic Syndrom and Related Disorders, Vol. 4, No. 3, 2006, pp. 204-214. doi:10.1089/met.2006.4.204
 M. Al-Nozha, A. Al-Khadra, M. R. Arafah, M. A. Al-Maatouq, M. Z. Khalil, N. B. Khan, Y. Y. Al-Mazrou, et al., “Metabolic Syndrome in Saudi Arabia,” Saudi Medical Journal, Vol. 26, No. 12, 2005, pp. 1918-1925.
 I. E. Barrimah, A. Mohaimeed, F. Midhat and H. A. Al-Shobiliet, “Prevalence of Metabolic Syndrome among Qassim University Personnel in Saudi Arabia,” International Journal of Health Sciences, Vol. 3, No. 2, 2009, pp. 133-142.
 N. M. Al-Daghri, O. S. Al-Attas, M. S. Alokail, K. M. Alkharfy, S. L. B. Sabico and G. P. Chrousos, “Decreasing Prevalence of the Full Metabolic Syndrome but a Persistently High Prevalence of Dyslipidemia among Adult Arabs,” Plos One, Vol. 5, No. 8, 2010, p. e12159. doi:10.1371/journal.pone.0012159
 Decode Study Group, “Prevalence of the Metabolic Syndrome in Populations of Asian Origin. Comparison of the Idf Definition with the Ncep Definition,” Diabetes Research and Clinical Practice, Vol. 76, No. 1, 2005, pp. 57-67.
 Decode Study Group, “Comparison of Different Definitions of the Metabolic Syndrome in Relation to Cardiovascular Mortality in European Men and Women,” Diabetologia, Vol. 49, No. 12, 2006, pp. 2837-2846.
 G. Assmann, R. Guerra, G. Fox, P. Cullen, H. Schulte, D. W. Willett and S. M. Grundy, “Harmonizing the Definition of Metabolic Syndrome: Comparison of the Criteria of the Adult Treatment Panel III and the International Diabetes Federation in U.S. American and European Populations,” American Journal of Cardiology, Vol. 99, No. 4, 2007, pp. 541-548.
 B. Cheung, K. Ong, Y. Man, L. Wong, C. Lau and K. Lam, “Prevalence of the Metabolic Syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 According to Different Defining Criteria,” The Journal of Clinical Hypertension, Vol. 8, No. 8, 2006, pp. 562-570.
 A. C. Santos and H. Barros, “Impact of Metabolic Syndrome Definitions on Prevalence Estimates: A Study in a Portuguese Community,” Diabetes and Vascular Disease Research, Vol. 4, No. 4, 2007, pp. 320-327.
 Y. Yoon, E. Lee, C. Park, S. Lee and S. Oh, “The New Definition of Metabolic Syndrome by the International Diabetes Federation Is Less Likely to Identify Metabolically Abnormal but Non-Obese Individuals than the Definition by the Revised National Cholesterol Education Program: The Korea Nhanes Study,” International Journal of Obesity, Vol. 31, No. 3, 2007, pp. 528-534.
 A. Gemalmaz, S. Aydin, O. Bafiak, G. Discigil and A. Karul, “Prevalence of the Metabolic Syndrome in a Rural Turkish Population: Comparison and Concordance of Two Diagnostic Criteria,” Turkish Journal of Medical Sciences, Vol. 38, No. 2, 2008, pp. 159-165.
 Y. W. Park, S. Zhu, L. Palaniappan, S. Heshka, M. R. Carnetho and S. B. Heymsfield, “Prevalence and Associated Risk Factor Findings in the Us Population from the Third National Health and Nutrition Examination Survey, 1988-1994,” Archives of Internal Medicine, Vol. 163, No. 4, 2003, pp. 427-436.
 L. Zhang, Q. Qiao, J. Tuomilehto, E. D. Janus, T. H. Lam, A. Ramachandran, V. Mohan, et al., “Distinct Ethnic Differences in Lipid Profiles across Glucose Categories,” The Journal of Clinical Endocrinology & Metabolism, Vol. 95, No. 4, 2010, pp. 1793-1801.
 K. F. Petersen, S. Dufour, D. Befroy, R. Garcia and G. I. Shulman, “Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes,” The New England Journal of Medicine, Vol. 350, No. 7, 2004, pp. 664-671.
 A. Laws, H. M. Hoen, J. V. Selby, M. F. Saad, S. M. Haffner and B. V. Howard, “Differences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status: Relation to Plasma Triglyceride and Apolipoprotein B Concentrations: Insulin Resistance Atherosclerosis Study (Iras) Investigators,” Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 1, 1997, pp. 64-71.
 X. L. Wang, L. Zhang, K. Youker, M. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, et al., “Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation through Upregulating PTEN or Inhibiting Akt Kinase,” Diabetes, Vol. 55, No. 8, 2006, pp. 2301-2310.
 S. M. Bahijri, E. M. Alissa, D. H. Akbar and T. M. Ghabrah, “Estimation of Insulin Resistance in Non-Diabetic Normotensive Saudi Adults by Quicki, Homa-Ir and Modified Quicki: A Comparative Study,” Annals of Saudi Medicine, Vol. 30, No. 4, 2010, pp. 257-264. doi:10.4103/0256-4947.65252